|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00512 GRAND PHARMA
Nominal 
0.000 (0.000%) Ranking Overview
Ranking based on 2 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
2
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 35.44 HKD (cts) | |
| Net Profit | 1,240.87 HKD (MIL) | DPS | 16.90 HKD (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (HKD (MIL)) |
EPS/ ((LPS)(HKD (cts)) |
DPS (HKD (cts)) |
Net Asset Value per Share (HKD) |
Highest (HKD (MIL)) |
Lowest (HKD (MIL)) |
| 2026 | 2,371.89 | 67.00 | -- | 2,397.00 | 2,346.78 | |
| 2027 | 2,686.92 | 76.00 | -- | 2,722.83 | 2,651.00 | |
| 2028 | 2,625.00 | 74.00 | -- | 2,625.00 | 2,625.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (HKD (MIL)) |
EPS*/ (LPS) (HKD (cts)) |
DPS * (HKD (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 2,397.00 | 68.00 | -- | CITIC SEC | Buy | 12.00 | 11/05/2026 | |
| 2026 | 2,346.78 | 66.00 | -- | GUOYUAN SEC | Buy | 11.88 | 12/12/2025 | |
| 2027 | 2,651.00 | 75.00 | -- | CITIC SEC | -- | -- | 11/05/2026 | |
| 2027 | 2,722.83 | 77.00 | -- | GUOYUAN SEC | -- | -- | 12/12/2025 | |
| 2028 | 2,625.00 | 74.00 | -- | CITIC SEC | -- | -- | 11/05/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 14/05/2026 07:37 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 1,240,871 |
| %Change | -49.729% |
| EPS / (LPS) | HKD 0.354 |
| NBV Per Share ($) | HKD 4.794 |